BIOSYNEX (EPA:ALBIO) | WebDisclosure

Basculer en Français

10082	Companies
206127	Keywords
136336	Articles
109268	Press releases

Home
Companies
BIOSYNEX

PRESS RELEASE

published on 03/04/2025 at 18:00, 1 year ago

BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER 2025
Déclaration du nombre d’actions et des droits de vote de BIOSYNEX SA au 28 février 2025. Le laboratoire français spécialisé en diagnostics de santé affiche 18 748 031 actions et 22 531 235 droits de vote

Déclaration Nombre D'actions Droits De Vote BIOSYNEX SA Diagnostic De Santé
BRIEF

published on 02/12/2025 at 08:05, 1 year 1 month ago

BIOSYNEX réussit son augmentation de capital

Augmentation De Capital Dilution Actionnaires Souscription BIOSYNEX Taux De Sursouscription
BRIEF

published on 02/12/2025 at 08:05, 1 year 1 month ago

BIOSYNEX successfully completes its capital increase

Capital Increase Subscription BIOSYNEX Dilution Of Shareholders Oversubscription Rate
PRESS RELEASE

published on 02/12/2025 at 08:00, 1 year 1 month ago

BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION
BIOSYNEX annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription, levée de fonds de 7,99 millions d'euros. Détails de l'opération et impact sur le capital et les actionnaires

Actionnaires Financement Augmentation De Capital Souscription BIOSYNEX
BRIEF

published on 01/22/2025 at 07:05, 1 year 2 months ago

Lancement de l'augmentation de capital par BIOSYNEX SA

Actionnaires Augmentation De Capital Souscription BIOSYNEX Droit Préférentiel De Souscription
BRIEF

published on 01/22/2025 at 07:05, 1 year 2 months ago

Launch of the capital increase by BIOSYNEX SA

Shareholders Capital Increase Subscription BIOSYNEX Preferential Subscription Right
PRESS RELEASE

published on 01/22/2025 at 07:00, 1 year 2 months ago

BIOSYNEX SA: LANCEMENT D’UNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION
PRESS RELEASE

published on 01/22/2025 at 07:00, 1 year 2 months ago

BIOSYNEX SA: LANCEMENT D’UNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION
L'entreprise BIOSYNEX SA lance une augmentation de capital avec maintien du droit préférentiel de souscription pour un montant cible de 7,99 millions d'euros. Détachement du DPS le 24 janvier 2025

Augmentation De Capital Droit Préférentiel De Souscription DPS BIOSYNEX SA Montant Cible
BRIEF

published on 01/13/2025 at 18:20, 1 year 2 months ago

Croissance et Restructuration : Biosynex en 2024

Croissance Économique Restructuration Ventes Export Division Pharmacie Division Diagnostic
BRIEF

published on 01/13/2025 at 18:20, 1 year 2 months ago

Growth and Restructuring: Biosynex in 2024

Restructuring Economic Growth Export Sales Pharmacy Division Diagnostic Division

Accesswire

Published on 03/24/2026 at 13:30, 2 hours 42 minutes ago

GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 2 hours 42 minutes ago

Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 3 hours 37 minutes ago

Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 3 hours 39 minutes ago

Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 3 hours 42 minutes ago

Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026

View all ACCESSWIRE

EQS Group

Published on 03/24/2026 at 16:02, 9 minutes ago

Custodian Property Income REIT plc: Share Buyback
Published on 03/24/2026 at 16:02, 10 minutes ago

EQS-Adhoc: JENOPTIK AG: Dr. Dominic Dorfner to become new CEO of JENOPTIK AG
Published on 03/24/2026 at 16:01, 10 minutes ago

Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Research GmbH): Buy
Published on 03/24/2026 at 15:45, 26 minutes ago

RITFIT Lands in Germany with Professional, Compact Strength Training Solutions for Urban Living
Published on 03/24/2026 at 15:41, 30 minutes ago

Invitation to the Annual Shareholders’ Meeting

Les Echos

Published on 03/24/2026 at 10:58, 5 hours 14 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 5 hours 14 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 8 hours 27 minutes ago

François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 8 hours 27 minutes ago

La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 8 hours 42 minutes ago

Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions

View all LES ECHOS COMFI WIRE